Real-time enrollment status for this extensive-stage small cell lung carcinoma clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 5:41 AM UTC
| NCT Number | NCT07843940 |
| Recruiting Status | Recruiting |
| Condition | Extensive-stage Small Cell Lung Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 55 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 13, 2026 (Yesterday) |
As of October 14, 2026: Clinical trial NCT07843940 is currently recruiting participants. This phase1 study for extensive-stage small cell lung carcinoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07843940 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07843940 was last updated Yesterday (October 13, 2026). HelloStudys verifies this status automatically.